The reference parameters used in the two analytical methods included patient age, BMI, ascites status and metastasis, as well as cancer stage, histotype and grade, the size of residual site, the M1/M2 ratio of the TAMs and the COX-2 expression levels of the TAMs and cancer cells. The gene discussed is PTGS2; the disease is cancer.